Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity

v3.8.0.1
Stockholders' Equity
3 Months Ended
Mar. 31, 2018
Stockholders' Equity Note [Abstract]  
Shareholders' Equity and Share-based Payments [Text Block]
Note 5 - Stockholders’ Equity
 
Common Stock 
 
The Company is authorized to issue 50,000,000 common shares with a par value of $0.0001 per share, of which 15,000,000 shares are designated as “Class A common stock.” As of March 31, 2018, there were 7,000,000 shares of Class A common stock issued and outstanding to Fortress. Dividends are to be distributed pro-rata to the Class A and common stock holders. The holders of common stock are entitled to one vote per share of common stock held. The Class A common stock holders are entitled to a number of votes per share equal to 1.1 times a fraction, the numerator of which is the sum of the shares of outstanding common stock and the denominator of which is the number of shares of Class A common stock. Accordingly, the holder of shares of Class A common stock will be able to control or significantly influence all matters requiring approval by our stockholders, including the election of directors and the approval of mergers or other business combination transactions. Each share of Class A common stock is convertible, at the option of the holder thereof, into one (1) fully paid and non-assessable share of common stock subject to adjustment for stock splits and combinations.
 
In November 2017, the Company filed a shelf registration statement on Form S-3 (the "S-3"), which was declared effective in December 2017. Under the S-3, the Company may sell up to a total of $100 million of its securities. In connection with the S-3, the Company entered into an At-the-Market Issuance Sales Agreement (the "ATM") with Cantor Fitzgerald &; Co., Ladenburg Thalmann &; Co. Inc. and H.C. Wainwright &; Co., LLC (each a "Agent" and collectively, the "Agents"), relating to the sale of shares of common stock. Under the ATM, the Company pays the Agents a commission rate of up to 3.0% of the gross proceeds from the sale of any shares of common stock.
 
During the three months ended March 31, 2018, the Company did not sell any shares of common stock under the ATM.
  
Pursuant to the Founders Agreement, the Company issued 591,836 shares of common stock to Fortress for the Annual Equity Fee, representing 2.5% of the fully-diluted outstanding equity of Checkpoint on January 1, 2018 (see Notes 2 and 4).
 
In March 2018, the Company completed an underwritten public offering, whereby it sold 5,290,000 shares of its common stock at a price of $4.35 per share for gross proceeds of approximately $23.0 million. Total net proceeds from the offering were approximately $20.8 million, net of underwriting discounts and offering expenses of approximately $2.2 million. The shares were sold under a Registration Statement (No. 333-221493) on Form S-3, filed by the Company with the SEC.
 
Pursuant to the Founders Agreement, the Company issued to Fortress 2.5% of the aggregate number of shares of common stock issued in the offering noted above. Accordingly, the Company issued 132,250 shares to Fortress on March 12, 2018 and recorded expense of approximately $641,000 related to this stock grant, which is included in general and administrative expenses in the Company’s Statements of Operations for the three months ended March 31, 2018.
 
The S-3 is currently the Company’s only active shelf registration statement. Subsequent to the underwritten public offering that was completed on March 12, 2018, approximately $77.0 million of the shelf remains available for sale under the S-3. The Company may offer the securities under the S-3 from time to time in response to market conditions or other circumstances if it believes such a plan of financing is in the best interests of its stockholders. The Company believes that the S-3 provides it with the flexibility to raise additional capital to finance its operations as needed.
 
Equity Incentive Plan
 
The Company has in effect the Amended and Restated 2015 Incentive Plan (“2015 Incentive Plan’). The 2015 Incentive Plan was adopted in March 2015 by our stockholders. Under the 2015 Incentive Plan, the compensation committee of the Company’s board of directors is authorized to grant stock-based awards to directors, officers, employees and consultants. An amendment to the 2015 Incentive Plan was approved by stockholders in June 2017 to increase the shares available for issuance to 5,000,000 shares. The plan expires 10 years from the effective date of the amendment and limits the term of each option to no more than 10 years from the date of grant.
 
As of March 31, 2018, 2,486,697 shares are available for issuance under the 2015 Incentive Plan.
 
Restricted Stock
 
The following table summarizes restricted stock award activity for the three months ended March 31, 2018:
 
 
 
Number of Units
 
Weighted Average
Grant Date Fair
Value
 
Nonvested at December 31, 2017
 
 
2,611,116
 
$
3.89
 
Granted
 
 
475,000
 
 
4.00
 
Vested
 
 
(70,313)
 
 
0.06
 
Nonvested at March 31, 2018
 
 
3,015,803
 
$
4.00
 
 
As of March 31, 2018, there was $4.3 million of total unrecognized compensation cost related to non-vested restricted stock, which is expected to be recognized over a weighted-average period of 2.6 years. This amount does not include 333,334 shares of restricted stock outstanding as of March 31, 2018 which are performance-based and vest upon achievement of certain corporate milestones. Stock-based compensation for these awards will be measured and recorded if and when it is probable that the milestone will be achieved.
 
Stock Options
 
The following table summarizes stock option award activity for the three months ended March 31, 2018:
 
 
 
Stock Options
 
Weighted Average
Exercise Price
 
Weighted Average
Remaining
Contractual Life
(in years)
 
Outstanding as of December 31, 2017
 
 
60,000
 
$
5.43
 
 
9.09
 
Granted
 
 
-
 
 
-
 
 
 
 
Outstanding as of March 31, 2018
 
 
60,000
 
$
5.43
 
 
8.84
 
 
 
 
 
 
 
 
 
 
 
 
 
Upon the exercise of stock options, the Company will issue new shares of its common stock.
  
Warrants
 
A summary of warrant activities for the three months ended March 31, 2018 is presented below:
 
 
 
Warrants
 
Weighted Average Exercise Price
 
Weighted Average Remaining
Contractual Life (in years)
 
Outstanding as of December 31, 2017
 
 
4,326,555
 
$
6.62
 
 
3.67
 
Exercised
 
 
(13,573)
 
 
-
 
 
 
 
Outstanding as of March 31, 2018
 
 
4,312,982
 
$
6.64
 
 
3.11
 
 
 
 
 
 
 
 
 
 
 
 
 
Upon the exercise of warrants, the Company will issue new shares of its common stock.
 
Stock-Based Compensation
 
The following table summarizes stock-based compensation expense for the three months ended March 30, 2018 and 2017 (in thousands).
 
 
 
For the three months ended March 31,
 
 
 
2018
 
2017
 
Research and development
 
$
680
 
$
406
 
General and administrative
 
 
457
 
 
573
 
Total stock-based compensation expense
 
$
1,137
 
$
979